Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC213203.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LAMP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PI4K2A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | STX6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SPINK2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | UBL3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | RP11-463C8.4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RCN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | B3GAT2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |